Fig. 2From: Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapyKaplan Meier curves for overall survival (a) and progression-free survival (b) according to diagnosis of type 2 diabetes mellitus (T2DM) in the whole cohort (n = 170). Patients with T2DM diagnosis had significantly shorter median OS and PFS compared with patients without T2DM history. Abbreviations: Overall Survival (OS), Progression Free Survival (PFS)Back to article page